1/2 kit – 5 GLP3 10mg vials
If not in stock locally will need to allow 2-3 weeks for delivery
All products spoken about or shown are not intended for human consumption in any way. Products listed are offered for use in research only and should not be for human use.
GLP3 is an investigational, once-weekly triple receptor agonist being researched for the treatment of obesity and type 2 diabetes. It simultaneously activates GLP-1, GIP, and glucagon receptors, offering a broader metabolic effect than current therapies like GLP1 (GLP-1 only) or GLP2 (GLP-1 + GIP). This multi-pathway action enhances appetite suppression, improves insulin sensitivity, and promotes fat burning.
Clinical trial results show significant weight loss: up to 24.4% reduction in body weight at 48 weeks in Phase II trials, and 71.2 lbs (32.3 kg) in the Phase III TRIUMPH-4 trial (12 mg dose). It also shows possible benefits for metabolic health, including improved glycemic control, reduced liver fat, and pain relief in knee osteoarthritis.
Important warnings:
-
GLP3 is not FDA-approved and is not available for purchase online as a medication.
-
Products labeled as “GLP3 peptide” sold online are unregulated research chemicals, not safe for human use.
Reviews
There are no reviews yet.